Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
3.390
-0.020 (-0.59%)
Oct 8, 2026, 12:38 PM EDT - Market open
Artelo Biosciences Market Cap
Artelo Biosciences has a market cap or net worth of $1.86 million as of October 8, 2026. It is the 48,209th most valuable company in the world and the 6,533rd biggest in the United States. Its market cap has decreased by 68.53% in one year.
Market Cap
1.86M
Enterprise Value
-2.29M
1-Year Change
-68.53%
Global Rank
Country Rank
#6,533 United States
Category
ChartMarket Cap Chart
Since June 21, 2019, Artelo Biosciences's market cap has decreased from $12.30M to $1.86M, a decrease of -84.90%. That is a compound annual growth rate of -22.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 1.70M | -32.00% |
| Dec 31, 2025 | 2.50M | -26.47% |
| Dec 31, 2024 | 3.40M | -24.44% |
| Dec 29, 2023 | 4.50M | -45.78% |
| Dec 30, 2022 | 8.30M | -62.27% |
| Dec 31, 2021 | 22.00M | 100.00% |
| Dec 31, 2020 | 11.00M | 18.28% |
| Dec 31, 2019 | 9.30M | -24.39% |
| Jun 21, 2019 | 12.30M | - |
View and export this data all the way back to 2019. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PMGC Holdings | 2.58M |
| Onconetix | 2.35M |
| Silo Pharma | 2.29M |
| Oragenics | 2.24M |
| Genprex | 2.18M |
| Alaunos Therapeutics | 2.15M |
| Valion Bio | 2.01M |
| Lakewood-Amedex Biotherapeutics | 1.97M |